{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T10:32:57Z","timestamp":1793010777581,"version":"4.5.0"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2027,3,1]],"date-time":"2027-03-01T00:00:00Z","timestamp":1803859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100019065","name":"Tianjin Municipal Science and Technology Program","doi-asserted-by":"publisher","award":["2025ZNSFSC0887"],"award-info":[{"award-number":["2025ZNSFSC0887"]}],"id":[{"id":"10.13039\/501100019065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["02063263133"],"award-info":[{"award-number":["02063263133"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["2682025CX047"],"award-info":[{"award-number":["2682025CX047"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52373153"],"award-info":[{"award-number":["52373153"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["52293383"],"award-info":[{"award-number":["52293383"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006606","name":"Natural Science Foundation of Tianjin Municipality","doi-asserted-by":"publisher","award":["24JCYBJC01790"],"award-info":[{"award-number":["24JCYBJC01790"]}],"id":[{"id":"10.13039\/501100006606","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2022YFA1205702"],"award-info":[{"award-number":["2022YFA1205702"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioactive Materials"],"published-print":{"date-parts":[[2027,3]]},"DOI":"10.1016\/j.bioactmat.2026.10.003","type":"journal-article","created":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T22:14:06Z","timestamp":1791756846000},"page":"319-334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cytotoxic T lymphocyte-inspired nanotherapeutics chaperoning granzyme B for tumor immune remodeling"],"prefix":"10.1016","volume":"69","author":[{"given":"Yujie","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongji","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinpu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feihe","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9534-795X","authenticated-orcid":false,"given":"Linqi","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioactmat.2026.10.003_bib1","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s41423-024-01207-0","article-title":"CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors","volume":"21","author":"Peng","year":"2024","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/s41392-024-01979-x","article-title":"Cold and hot tumors: from molecular mechanisms to targeted therapy","volume":"9","author":"Wu","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1371743","article-title":"Granzymes in health and diseases: the good, the bad and the ugly","volume":"15","author":"Cigalotto","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib4","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1016\/j.immuni.2023.09.011","article-title":"The cancer-immunity cycle: indication, genotype, and immunotype","volume":"56","author":"Mellman","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.bioactmat.2026.10.003_bib5","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1007\/s12672-025-03745-z","article-title":"From cold to hot tumors: feasibility of applying therapeutic insights to TNBC","volume":"16","author":"Yan","year":"2025","journal-title":"Discov. Oncol."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1344272","article-title":"Overcoming cold tumors: a combination strategy of immune checkpoint inhibitors","volume":"15","author":"Ouyang","year":"2024","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.754436","article-title":"Kickstarting immunity in cold tumours: localised tumour therapy combinations with immune checkpoint blockade","volume":"12","author":"Appleton","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib8","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/s41467-025-56527-0","article-title":"Unlocking the potential of engineered immune cell therapy for solid tumors","volume":"16","author":"Albarr\u00e1n-Fern\u00e1ndez","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib9","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41392-025-02269-w","article-title":"CAR-T cell therapy for cancer: current challenges and future directions","volume":"10","author":"Zugasti","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib10","article-title":"CAR-T cells in solid tumors: challenges and breakthroughs","volume":"6","author":"Escobar","year":"2025","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib11","article-title":"NK cells, and tumor-associated macrophages in cancer immunotherapy and the current state of the art of drug delivery systems","volume":"14","author":"Yang","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib12","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1126\/science.aay9207","article-title":"Supramolecular attack particles are autonomous killing entities released from cytotoxic T cells","volume":"368","author":"B\u00e1lint","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.bioactmat.2026.10.003_bib13","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.1038\/s41467-023-41634-7","article-title":"Modulation of lytic molecules restrain serial killing in \u03b3\u03b4 T lymphocytes","volume":"14","author":"Sandoz","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib14","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1038\/cdd.2009.206","article-title":"Granzymes in cancer and immunity","volume":"17","author":"Cullen","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib15","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1038\/s41467-021-25282-3","article-title":"Cytotoxic T cells are able to efficiently eliminate cancer cells by additive cytotoxicity","volume":"12","author":"Weigelin","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrd2399","article-title":"Protein therapeutics: a summary and pharmacological classification","volume":"7","author":"Leader","year":"2008","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib17","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/s43018-023-00600-4","article-title":"CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D\u2013NKG2DL axis","volume":"4","author":"Lerner","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.bioactmat.2026.10.003_bib18","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1038\/s41467-023-40850-5","article-title":"Desmoplastic stroma restricts T cell extravasation and mediates immune exclusion and immunosuppression in solid tumors","volume":"14","author":"Xiao","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib19","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jconrel.2024.04.017","article-title":"Co-encapsulation of granzyme B and perforin in nanocapsules for tumour therapy: biomimicking immune cells","volume":"369","author":"Shi","year":"2024","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2026.10.003_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121723","article-title":"Inhibition of SerpinB9 to enhance granzyme B-based tumor therapy by using a modified biomimetic nanoplatform with a cascade strategy","volume":"288","author":"Han","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2026.10.003_bib21","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jconrel.2022.04.048","article-title":"ApoE-mediated systemic nanodelivery of granzyme B and CpG for enhanced glioma immunotherapy","volume":"347","author":"Wei","year":"2022","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2026.10.003_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcis.2025.137829","article-title":"Cyclized polyacrylonitrile nanoparticles: enhanced intratumoral delivery by photocatalysis and collagen denaturation","volume":"696","author":"Xu","year":"2025","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib23","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41573-020-0090-8","article-title":"Engineering precision nanoparticles for drug delivery","volume":"20","author":"Mitchell","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2024.115387","article-title":"Subcellular targeting strategies for protein and peptide delivery","volume":"212","author":"Su","year":"2024","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib25","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1038\/s41467-023-38841-7","article-title":"In vivo CRISPR screens reveal Serpinb9 and Adam 2 as regulators of immune therapy response in lung cancer","volume":"14","author":"Dervovic","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib26","doi-asserted-by":"crossref","first-page":"7616","DOI":"10.7150\/thno.35900","article-title":"A novel Granzyme B nanoparticle delivery system simulates immune cell functions for suppression of solid tumors","volume":"9","author":"Qian","year":"2019","journal-title":"Theranostics"},{"key":"10.1016\/j.bioactmat.2026.10.003_bib27","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1038\/s41467-026-70859-5","article-title":"Programmable nanomicelles rewire myeloid immunity for durable control of primary and metastatic breast cancer","volume":"17","author":"Yang","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib28","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1038\/s41565-024-01754-7","article-title":"A translational framework to DELIVER nanomedicines to the clinic","volume":"19","author":"Joyce","year":"2024","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.7150\/thno.117363","article-title":"Neutrophil-based delivery platforms: from natural mechanisms to engineered therapeutics","volume":"16","author":"Li","year":"2026","journal-title":"Theranostics"},{"key":"10.1016\/j.bioactmat.2026.10.003_bib30","doi-asserted-by":"crossref","first-page":"7319","DOI":"10.1038\/s41467-026-74247-x","article-title":"Supercharged ferritin nanocages enable universal cytosolic protein delivery","volume":"17","author":"Liu","year":"2026","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2025.107628","article-title":"Development of chimeric nanobody-granzyme B functionalized ferritin nanoparticles for precise tumor therapy","volume":"213","author":"Xia","year":"2025","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib32","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1016\/j.apsb.2022.04.013","article-title":"Tailoring combinatorial lipid nanoparticles for intracellular delivery of nucleic acids, proteins, and drugs","volume":"12","author":"Li","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioactmat.2026.10.003_bib33","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41392-025-02439-w","article-title":"Navigating the landscape of protein folding and proteostasis: from molecular chaperones to therapeutic innovations","volume":"10","author":"Kuzu","year":"2025","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib34","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1038\/s41467-021-22369-9","article-title":"The landscape of molecular chaperones across human tissues reveals a layered architecture of core and variable chaperones","volume":"12","author":"Shemesh","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib35","article-title":"Mimicking molecular chaperones to regulate protein folding","volume":"32","author":"Ma","year":"2020","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib36","article-title":"Synergizing CXCL9 with BRD4-PROTAC using nanochaperone boosts robust T cell-dependent antitumor immune responses for cancer immunotherapy","volume":"34","author":"Chen","year":"2024","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib37","article-title":"Holdase\/Foldase mimetic nanochaperone improves antibody-based cancer immunotherapy","volume":"7","author":"Zhang","year":"2023","journal-title":"Small Methods"},{"key":"10.1016\/j.bioactmat.2026.10.003_bib38","article-title":"In situ antigen-capturing nanochaperone toward personalized nanovaccine for cancer immunotherapy","volume":"18","author":"Li","year":"2022","journal-title":"Small"},{"key":"10.1016\/j.bioactmat.2026.10.003_bib39","article-title":"Controlled refolding of denatured IL-12 using in situ antigen-capturing nanochaperone remarkably reduces the systemic toxicity and enhances cancer immunotherapy","volume":"36","author":"Zhang","year":"2024","journal-title":"Adv. Mater."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib40","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1039\/c2cs15327k","article-title":"Design of polymeric nanoparticles for biomedical delivery applications","volume":"41","author":"Elsabahy","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib41","doi-asserted-by":"crossref","first-page":"5969","DOI":"10.1039\/c2cs35115c","article-title":"Self-assembly of block copolymers","volume":"41","author":"Mai","year":"2012","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib42","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/nri911","article-title":"Functional significance of the perforin\/granzyme cell death pathway","volume":"2","author":"Trapani","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib43","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/ni.2050","article-title":"Perforin pores in the endosomal membrane trigger the release of endocytosed granzyme B into the cytosol of target cells","volume":"12","author":"Thiery","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib44","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3390\/biomedicines6020072","article-title":"Human granzyme B based targeted cytolytic fusion proteins","volume":"6","author":"Hlongwane","year":"2018","journal-title":"Biomedicines"},{"key":"10.1016\/j.bioactmat.2026.10.003_bib45","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/s41416-023-02361-4","article-title":"Resistance to immune checkpoint therapies by tumour-induced T-cell desertification and exclusion: key mechanisms, prognostication and new therapeutic opportunities","volume":"129","author":"Wang","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.bioactmat.2026.10.003_bib46","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1016\/j.immuni.2023.09.005","article-title":"CD8+ T cells in the cancer-immunity cycle","volume":"56","author":"Giles","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.bioactmat.2026.10.003_bib47","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ccell.2022.09.011","article-title":"Technology meets TILs: deciphering T cell function in the -omics era","volume":"41","author":"Hudson","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bioactmat.2026.10.003_bib48","article-title":"Oxidative stress and cellular senescence: roles in tumor progression and therapeutic opportunities","volume":"3","author":"Jin","year":"2024","journal-title":"MedComm Oncol"},{"key":"10.1016\/j.bioactmat.2026.10.003_bib49","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1038\/s41467-023-41282-x","article-title":"Stressed target cancer cells drive nongenetic reprogramming of CAR T cells and solid tumor microenvironment","volume":"14","author":"Wang","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib50","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/s41573-021-00189-2","article-title":"Navigating CAR-T cells through the solid-tumour microenvironment","volume":"20","author":"Hou","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.bioactmat.2026.10.003_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2022.121567","article-title":"Approaches and materials for endocytosis-independent intracellular delivery of proteins","volume":"286","author":"Chen","year":"2022","journal-title":"Biomaterials"},{"key":"10.1016\/j.bioactmat.2026.10.003_bib52","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jconrel.2024.01.067","article-title":"E3MPH16: an efficient endosomolytic peptide for intracellular protein delivery","volume":"367","author":"Kawaguchi","year":"2024","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.bioactmat.2026.10.003_bib53","doi-asserted-by":"crossref","first-page":"3680","DOI":"10.1016\/j.apsb.2024.03.010","article-title":"Dendritic nanomedicine enhances chemo-immunotherapy by disturbing metabolism of cancer-associated fibroblasts for deep penetration and activating function of immune cells","volume":"14","author":"Li","year":"2024","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.bioactmat.2026.10.003_bib54","doi-asserted-by":"crossref","DOI":"10.5772\/intechopen.1005693","article-title":"Activation of adenosine phosphate signaling promotes antitumor immunity in tumor microenvironment and facilitate immunotherapy","volume":"4","author":"Xu","year":"2025","journal-title":"MedComm Oncol"}],"container-title":["Bioactive Materials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X26005852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2452199X26005852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T09:38:26Z","timestamp":1793007506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2452199X26005852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2027,3]]},"references-count":54,"alternative-id":["S2452199X26005852"],"URL":"https:\/\/doi.org\/10.1016\/j.bioactmat.2026.10.003","relation":{},"ISSN":["2452-199X"],"issn-type":[{"value":"2452-199X","type":"print"}],"subject":[],"published":{"date-parts":[[2027,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytotoxic T lymphocyte-inspired nanotherapeutics chaperoning granzyme B for tumor immune remodeling","name":"articletitle","label":"Article Title"},{"value":"Bioactive Materials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioactmat.2026.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}